Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review
P Csermely, T Korcsmáros, HJM Kiss, G London… - Pharmacology & …, 2013 - Elsevier
Despite considerable progress in genome-and proteome-based high-throughput screening
methods and in rational drug design, the increase in approved drugs in the past decade did …
methods and in rational drug design, the increase in approved drugs in the past decade did …
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
DB Kell - BMC medical genomics, 2009 - Springer
Background The production of peroxide and superoxide is an inevitable consequence of
aerobic metabolism, and while these particular'reactive oxygen species'(ROSs) can exhibit a …
aerobic metabolism, and while these particular'reactive oxygen species'(ROSs) can exhibit a …
HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology
C Gille, C Bölling, A Hoppe, S Bulik… - Molecular systems …, 2010 - embopress.org
We present HepatoNet1, the first reconstruction of a comprehensive metabolic network of
the human hepatocyte that is shown to accomplish a large canon of known metabolic liver …
the human hepatocyte that is shown to accomplish a large canon of known metabolic liver …
Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics
The chemical identification of mass spectrometric signals in metabolomic applications is
important to provide conversion of analytical data to biological knowledge about metabolic …
important to provide conversion of analytical data to biological knowledge about metabolic …
Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles
J Tang, T Aittokallio - Current pharmaceutical design, 2014 - ingentaconnect.com
Polypharmacology has emerged as novel means in drug discovery for improving treatment
response in clinical use. However, to really capitalize on the polypharmacological effects of …
response in clinical use. However, to really capitalize on the polypharmacological effects of …
A review on computational systems biology of pathogen–host interactions
Pathogens manipulate the cellular mechanisms of host organisms via pathogen–host
interactions (PHIs) in order to take advantage of the capabilities of host cells, leading to …
interactions (PHIs) in order to take advantage of the capabilities of host cells, leading to …
In silico models of cancer
Cancer is a complex disease that involves multiple types of biological interactions across
diverse physical, temporal, and biological scales. This complexity presents substantial …
diverse physical, temporal, and biological scales. This complexity presents substantial …
Systems medicine and metabolic modelling
A Mardinoglu, J Nielsen - Journal of internal medicine, 2012 - Wiley Online Library
Mardinoglu A, Nielsen J (University of Technology, Gothenburg, Sweden). Systems
medicine and metabolic modelling (Key Symposium). J Intern Med 2012; 271: 142–154 …
medicine and metabolic modelling (Key Symposium). J Intern Med 2012; 271: 142–154 …
Integrating cellular metabolism into a multiscale whole-body model
Cellular metabolism continuously processes an enormous range of external compounds into
endogenous metabolites and is as such a key element in human physiology. The …
endogenous metabolites and is as such a key element in human physiology. The …
PubChem as a source of polypharmacology
Polypharmacology provides a new way to address the issue of high attrition rates arising
from lack of efficacy and toxicity. However, the development of polypharmacology is …
from lack of efficacy and toxicity. However, the development of polypharmacology is …